STOCK TITAN

Exact Sciences to participate in J.P. Morgan Healthcare Conference

Exact Sciences Corp. (Nasdaq: EXAS) will participate in the J.P.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Exact Sciences Corp. (Nasdaq: EXAS) will participate in the J.P. Morgan Healthcare Conference on January 13, 2021, at 2:50 p.m. EST. Investors can join the discussion via webcast, accessible through the investor relations section of Exact Sciences' website.

This leading cancer diagnostics company aims to advance patient care and tackle deadly cancers through innovative solutions. For more details, visit exactsciences.com.

Loading...
Loading translation...
Argus Session date unavailable
-2.72% session move Open Argus
Details

News Market Reaction – EXAS

The recorded move for EXAS in the trading session of this news was -2.72%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MADISON, Wis., Dec. 28, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • J.P. Morgan Healthcare Conference
    Presentation followed by a Q&A session on Wednesday, January 13, 2021 at 2:50 p.m. EST

The webcast can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-jp-morgan-healthcare-conference-301198542.html

SOURCE EXACT SCIENCES CORP

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Exact Sciences participate in the J.P. Morgan Healthcare Conference?

Exact Sciences will participate in the J.P. Morgan Healthcare Conference on January 13, 2021, at 2:50 p.m. EST.

How can investors access the Exact Sciences conference webcast?

Investors can access the webcast of the Exact Sciences conference through the investor relations section of their website.

What is the stock symbol for Exact Sciences?

The stock symbol for Exact Sciences is EXAS.

What is Exact Sciences known for?

Exact Sciences is known for providing cancer screening and diagnostic tests, including Cologuard and Oncotype DX.

Keep reading